Evidence map›Paper›PMID 35899485›Full record

ArticleDermatologic therapy2022

Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report.

Federica Gelato, Luca Mastorino, Paola Cavalla, Pietro Quaglino, Giovanni Cavaliere, Marco Vercellino, Chiara Bosa, Matilde Inglese, Raffaele De Palma, Michela Ortoncelli and 1 more

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Managing Atopic Dermatitis with Dupilumab in Special Populations: A Case Series Study.Clinical, cosmetic and investigational dermatology · 2025
    Article
  3. Two-sample Mendelian randomization analysis of causal relationship between eczema and autoimmune diseases.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Federica GelatoDermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-7028-0322
Luca MastorinoDermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-7386-3219
Paola CavallaDepartment of Neurosciences and Mental Health, City of Health and Science University Hospital of Turin, Turin, Italy.
Pietro QuaglinoDermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
Giovanni CavaliereDermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
Marco VercellinoDepartment of Neurosciences and Mental Health, City of Health and Science University Hospital of Turin, Turin, Italy.
Chiara BosaDepartment of Neurosciences, University of Turin, Turin, Italy.
Matilde IngleseDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research, University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Raffaele De PalmaDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research, University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Michela OrtoncelliDermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
Simone RiberoDermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-0098-1406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dermatitis, AtopicMultiple SclerosisAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedHumansTreatment OutcomeAntibodies, MonoclonalAntibodies, Monoclonal, Humanizeddupilumab

Identifiers

PMID35899485
PMCPMC9788158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.